Details for Patent: 11,376,251
✉ Email this page to a colleague
Which drugs does patent 11,376,251 protect, and when does it expire?
Patent 11,376,251 protects LIVMARLI and is included in one NDA.
This patent has seventy-five patent family members in twenty-one countries.
Summary for Patent: 11,376,251
Title: | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
Abstract: | Provided herein are methods of treating or ameliorating a pediatric cholestatic liver disease by non-systemically administering to an individual in need thereof a therapeutically effective amount of a pediatric formulation comprising an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTI) or a pharmaceutically acceptable salt thereof. Also provided are methods for treating or ameliorating a pediatric liver disease, decreasing the levels of serum bile acids or hepatic bile acids, treating or ameliorating pruritis, reducing liver enzymes, or reducing bilirubin comprising non-systemically administering to an individual in need thereof a therapeutically effective amount of a pediatric formulation comprising an ASBTI or a pharmaceutically acceptable salt thereof. |
Inventor(s): | Gedulin; Bronislava (Del Mar, CA), Grey; Michael (Rancho Sante Fe, CA), O'Donnell; Niall (Encintas, CA) |
Assignee: | Shire Human Genetic Therapies, Inc. (Lexington, MA) |
Application Number: | 17/498,586 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 11,376,251
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mirum | LIVMARLI | maralixibat chloride | SOLUTION;ORAL | 214662-001 | Sep 29, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH ALAGILLE SYNDROME (ALGS) | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,376,251
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2012328453 | ⤷ Try a Trial | |||
Australia | 2012328526 | ⤷ Try a Trial | |||
Australia | 2017210623 | ⤷ Try a Trial | |||
Australia | 2017213485 | ⤷ Try a Trial | |||
Australia | 2019202884 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |